focus -WSS

focus

author：leisure time 2025-10-01 11:44:42 - browse：79

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Ukraine taking heavy casualties 10 weeks into its counteroffensive

focus

WSS

Inside the culture of fear in the White House science office of Eric Lander

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Patient advocates sound warning on FDA proposal on salt intake

The pain doctors face in trying to build their families

FDA approves first blood sugar monitor without finger pricks

Clinical trials must include more disabled people

focus

focus

focus

Activists slam private health insurers over coverage restrictions

How a key Senate committee is planning to regulate PBMs

DIEP, the 'gold standard' of breast reconstruction, is under threat

4 missing after record

At least 13 dead in Texas as scorching temps continue

The response to Covid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Inside the culture of fear in the White House science office of Eric Lander

After affirmative action ruling, medical educators look to 'holistic review'

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

hotspot

As Maui death toll rises, number of missing remains unclear

FDA approves first blood sugar monitor without finger pricks

Listen: Racing for gene therapy & a pioneering approval

The response to Covid

Liz Cheney makes 1st public comment since Trump's election interference indictments

Sophia Smith scores twice for US in in 3

focus

focus

Wikipedia

hotspot